Scientists, industry and government leaders join the 8th annual event in New York City to explore bioelectronic medicine

Science, technology and health care converge in the new field of bioelectronic medicine, which is poised to transform not only health outcomes, but society, the economy and culture at large. This rapidly evolving specialty of medicine turns to devices instead of drugs to heal the body, fundamentally changing how we treat disease. To explore this groundbreaking discipline, Northwell Health’s 8th annual Constellation Forum will convene scientists, innovators, investors, government leaders and disruptors for a two-day event in New York City on October 22 and 23.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015197111/en/

Northwell Health’s 8th annual Constellation Forum will focus on bioelectronic medicine.

To join virtually or apply to participate in-person, register at www.ConstellationForum.com.

Hosted by John D’Angelo, MD, Northwell’s president and CEO, the forum will gather insights from speakers representing organizations such as the Food and Drug Administration (FDA), Medtronic, Cleveland Clinic, Centers for Medicare & Medicaid Services (CMS), SetPoint Medical, Karolinska Institutet, among others. These experts will highlight breakthroughs and achievements, discuss commercialization and investment strategies and address the critical challenges for scaling bioelectronic medicine into everyday care.

“Innovation, the kind that transforms health care, flourishes when we bring different perspectives together. At Northwell’s Constellation Forums, we’ve seen how converging clinical and scientific expertise with creative thinking leads to breakthroughs,” said Dr. D’Angelo. “I know this year’s Forum will generate new solutions and drive life-changing treatment options that were once unimaginable and will benefit our communities for years to come.”

The forum builds upon the recent news of the FDA’s landmark approval of the first vagus nerve stimulation device to treat rheumatoid arthritis. Developed by SetPoint Medical, this groundbreaking technology is built upon more than three decades of scientific discoveries led by Kevin J. Tracey, MD, president and CEO of Northwell’s Feinstein Institutes for Medical Research, the Karches Family Distinguished Chair in Medical Research, co-founder and now advisor of SetPoint Medical, and labs worldwide. During a special session, Dr. Tracey will discuss how the unmet needs of patients elevate the importance of translating basic science discoveries into clinically useful therapies, and how the recent FDA approval for the SetPoint Medical immunoregulator positions the field of bioelectronics as a major medical, financial, and cultural disrupter.

Other notable speakers include:

• Ami Bhatt, MD, chief innovation officer, American College of Cardiology; chair, Digital Health Advisory Committee, FDA
• Leonard Calabrese, DO, professor of Medicine and vice chair of the Department of Rheumatic and Immunologic Diseases, Cleveland Clinic
• Jeff Dunkel, CEO, Optain Health
• Bunny Ellerin, CEO, Digital Health NY
• Kristoffer Famm, PhD, president and CEO, Galvani Bioelectronics
• Scott Gottlieb, MD, former commissioner, FDA; partner, New Enterprise Associates
• Hubert Lim, PhD, director of the Earl E. Bakken Medical Devices Center and professor of Biomedical Engineering and Otolaryngology, University of Minnesota
• Geoffrey Ling, MD, PhD, former director, DARPA Biological Technologies Office, serial entrepreneur; CEO, Ling and Associates
• Josh Makower, MD, co-founder and director, Stanford Biodesign
• Juan-Pablo Mas, partner, Action Potential Venture Capital
• John M. O'Brien, PharmD, president and CEO, National Pharmaceutical Council
• Peder Olofsson, MD, PhD, program director, Bioelectronic Medicine, Karolinska Institutet
• Kelly Owens, vagus nerve clinical trial participant
• Scott Rechler, CEO and chairman, RXR
• Amaza Reitmeier, vice president and general manager, neuromodulation portfolio and leader, Global Brain Health Solutions team, Medtronic
• Amy Rochlin, CEO, Complex Disorders Alliance
• Zack Scott, MD, general partner, Norwest
• Murthy Simhambhatla, PhD, president and CEO, SetPoint Medical
• Amy Turner, deputy director, Innovation Center, Centers for Medicare & Medicaid Services
• Lt. Col. Adam Willis, program manager, Biological Technologies Office – Defense Advanced Research Projects Agency

Northwell has fostered the development of bioelectronic medicine from scientific labs to the patient’s bed. The Feinstein Institutes– the scientific home of medical research for the health system – has conducted research in bioelectronic medicine for decades. Most recently, Northwell’s groundbreaking brain computer interface (BCI) implant technology and clinical trial that is allowing people living with paralysis to move and feel again, the Double Neural Bypass, has been named to TIME Best Inventions Hall of Fame. The list recognizes 25 groundbreaking inventions that had the most global impact since first appearing on the annual list in the past quarter century.

In 2024, Northwell established its first clinical Center for Bioelectronic Medicine to offer patients access to cutting-edge clinical trials and FDA-approved treatments. Last month, Northwell was the first health system in the nation to implant the SetPoint Medical system in patients to treat rheumatoid arthritis. To learn more about the Center, visit www.northwell.edu/center-for-bioelectronic-medicine or call 227-BIO-INST.

For more information about the program and its speakers and to register your attendance, please visit: www.constellationforum.com.

About Northwell Health

Northwell is the largest not-for-profit health system in the Northeast, serving residents of New York and Connecticut with 28 hospitals, more than 1,000 outpatient facilities, 22,000 nurses and over 20,000 physicians. Northwell cares for more than three million people annually in the New York metro area, including Long Island, the Hudson Valley, western Connecticut and beyond, thanks to philanthropic support from our communities. Northwell is New York State’s largest private employer with over 104,000 employees – including members of Northwell Health Physician Partners and Nuvance Health Medical Practices – who are working to change health care for the better. Northwell, named a TIME100 Most Influential Companies 2025, is making breakthroughs in medicine at the Feinstein Institutes for Medical Research. Northwell is training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, X, Instagram and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251015197111/en/